Global Medical Director, Epilepsy Pipeline

Job Description

If you are a current Jazz employee please apply via the Internal Career site.

\n

Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit for more information.

\n

\n
\n

The Global Medical Director, Epilepsy Pipeline is a key member of Global Commercialization Organization Medical Affairs (GCOMA) team and reports to the ED, Global Medical Franchise Lead, Epilepsy. This is a strategic role with execution responsibilities, accountable for ensuring the needs and priorities of the US and EUR/INT regions are represented and addressed through engagement with key partners across Jazz. Working closely with regional Medical Affairs colleagues, the Global Medical Director ensures a deep understanding of customer, patient, and healthcare system needs are represented consistently across global cross-functional discussions and decision-making forums. The role serves as a critical interface between Medical Affairs teams and global R&D, Global Product Development and Commercialization functions, partnering closely with US and EUR/INT colleagues to ensure regional insights and priorities are understood, communicated, and appropriately considered within the Global Product Team (GPT), Late Development Team (LDT), Medical Functional Matrix Team (FMT), and governance forums including the Portfolio Governance Committee (PGC) and Development Project Review Committee (DPRC). Success in this role requires strong partnership with regional teams, particularly in the US, to maintain close alignment with regional medical strategies and ensure that evidence generation activities and development plans address the needs of physicians, patients, and healthcare systems across regions.

\n
\n

  

\n

Essential Functions/Responsibilities:

\n

\n
• Lead the Medical FMT for ABS-1230 and support the epilepsy pipeline including other potential new indications across the epilepsy portfolio.
\n

\n
\n

\n
• Partner closely with US and EUR/INT Medical Affairs teams to understand regional customer, patient, healthcare provider, and healthcare system needs and priorities.
\n
• Represent and advocate for medical perspectives within global cross-functional teams and governance forums, including EDT, LDT, GPT, PGC, and DPRC.
\n
• Contribute Medical Affairs expertise to inform early development activities, including Target Product Profile (TPP) development, clinical trial design and lifecycle planning based on regional insights and aligned future therapeutic landscape scenarios.
\n
• Ensure regional needs and insights are appropriately considered in clinical development discussions, evidence-generation activities, and lifecycle planning
\n
• Ensure awareness and Medical Affairs functional alignment on clinical development programs
\n
• Maintain and apply a deep understanding of the competitive landscape to inform evidence generation strategy and internal development decisions.
\n
• Lead the development, maintenance, and execution of the Integrated Evidence Generation Plan (IEGP) for ABS-1230 and other pipeline assets for Jazz.
\n
• Partner effectively across Medical Affairs, Clinical Development, Regulatory Affairs, Market Access, HEOR, RWE, Commercial, and other cross-functional teams to support evidence generation and scientific exchange.
\n
• Lead and support evidence-generation activities, including investigator-sponsored studies, real-world evidence initiatives, health outcomes research, and Phase IV interventional studies, where appropriate.
\n
• Lead the development of the Epilepsy pipeline scientific narrative by identifying and advancing key analytic needs and informing the interpretation of pivotal trial data.
\n
• Lead development of publication strategy in partnership with the Medical Communications team and in alignment with regional evidence needs and scientific priorities.
\n
• Support scientific communications, congress planning, advisory boards, and external engagement activities as required.
\n
• Act as an epilepsy subject matter expert for internal cross-functional stakeholders.
\n

\n
\n

Required Knowledge, Skills, and Abilities

\n

Essential Functions/Responsibilities:

\n

\n
• Lead the Medical FMT for ABS-1230 and support the epilepsy pipeline including other potential new indications across the epilepsy portfolio.
\n
• Partner closely with US and EUR/INT Medical Affairs teams to understand regional customer, patient, healthcare provider, and healthcare system needs and priorities.
\n
• Represent and advocate for medical perspectives within global cross-functional teams and governance forums, including EDT, LDT, GPT, PGC, and DPRC.
\n
• Contribute Medical Affairs expertise to inform early development activities, including Target Product Profile (TPP) development, clinical trial design and lifecycle planning based on regional insights and aligned future therapeutic landscape scenarios.
\n
• Ensure regional needs and insights are appropriately considered in clinical development discussions, evidence-generation activities, and lifecycle planning
\n
• Ensure awareness and Medical Affairs functional alignment on clinical development programs
\n
• Maintain and apply a deep understanding of the competitive landscape to inform evidence generation strategy and internal development decisions.
\n
• Lead the development, maintenance, and execution of the Integrated Evidence Generation Plan (IEGP) for ABS-1230 and other pipeline assets for Jazz.
\n
• Partner effectively across Medical Affairs, Clinical Development, Regulatory Affairs, Market Access, HEOR, RWE, Commercial, and other cross-functional teams to support evidence generation and scientific exchange.
\n
• Lead and support evidence-generation activities, including investigator-sponsored studies, real-world evidence initiatives, health outcomes research, and Phase IV interventional studies, where appropriate.
\n
• Lead the development of the Epilepsy pipeline scientific narrative by identifying and advancing key analytic needs and informing the interpretation of pivotal trial data.
\n
• Lead development of publication strategy in partnership with the Medical Communications team and in alignment with regional evidence needs and scientific priorities.
\n
• Support scientific communications, congress planning, advisory boards, and external engagement activities as required.
\n
• Act as an epilepsy subject matter expert for internal cross-functional stakeholders.
\n

\n

Required Knowledge, Skills, and Abilities

\n

\n
• Significant (10+ years) Medical Affairs, Clinical Development, or related pharmaceutical or biotechnology industry experience, preferably in epilepsy and neuroscience disorders.
\n
• Strong clinical or scientific background in epilepsy therapeutic area.
\n
• Demonstrated experience developing and executing evidence-generation strategies, publication plans, and external scientific engagement activities.
\n
• Strong understanding of clinical research, evidence generation, and neuroscience drug development.
\n
• Proven ability to influence without authority and operate effectively within complex matrix organizations.
\n
• Strong strategic thinking coupled with excellent operational execution skills.
\n
• Excellent written, verbal, presentation, and stakeholder management skills.
\n
• Ability to build productive partnerships across regions and functions and effectively represent diverse stakeholder perspectives.
\n
• Demonstrated ability to manage multiple priorities and deliver high-quality outcomes in a fast-paced environment
\n
• Experience in lifecycle management of epilepsy/neuroscience indications strongly desired
\n
• Evidence of success in matrix organizations and track record of high performing behaviors, including independent critical thinking, initiative, and execution under time pressure with competing priorities
\n
• Self-awareness and emotional intelligence as demonstrated by prior experience navigating complex matrix environments successfully
  
\n

\n
\n

Required/Preferred Education and Licenses 

\n
\n

\n
• Advanced scientific or healthcare degree required (PharmD, PhD, MD, or equivalent).
\n

\n
\n

#LI-Remote

\n
\n \n

Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.

\n

FOR US BASED CANDIDATES ONLY

\n

Jazz Pharmaceuticals, Inc. is committed to fair and equitable compensation practices and we strive to provide employees with total compensation packages that are market competitive. For this role, the full and complete base pay range is: $268,000.00 - $402,000.00

\n

Individual compensation paid within this range will depend on many factors, including qualifications, skills, relevant experience, job knowledge, and other pertinent factors. The goal is to ensure fair and competitive compensation aligned with the candidate's expertise and contributions, within the established pay framework and our Total Compensation philosophy. Internal equity considerations will also influence individual base pay decisions. This range will be reviewed on a regular basis.

\n

At Jazz, your base pay is only one part of your total compensation package. The successful candidate may also be eligible for a discretionary annual cash bonus or incentive compensation (depending on the role), in accordance with the terms of the Company's Global Cash Bonus Plan or Incentive Compensation Plan, as well as discretionary equity grants in accordance with Jazz's Long Term Equity Incentive Plan.

\n

The successful candidate will also be eligible to participate in various benefits offerings, including, but not limited to, medical, dental and vision insurance, 401k retirement savings plan, and flexible paid vacation. For more information on our Benefits offerings please click here: